Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
Diabetes|November 10, 2007
Glucagon-like peptide-1 inhibits blood-brain glucose transfer in humansSusanne Lerche, Birgitte Brock, Jørgen Rungby, et al.
Therapeutic Advances in Gastroenterology|June 28, 2019
Pathophysiology and management of diabetic gastroenteropathyTheresa Meldgaard, Jutta Keller, Anne Estrup Olesen, et al.
Investigative Ophthalmology & Visual Science|August 18, 2022
Palpebral Fissure Response to Phenylephrine Indicates Autonomic Dysfunction in Patients With Type 1 Diabetes and PolyneuropathyThomas Arendt Nielsen, Carl Uggerhøj Andersen, Henrik Vorum, et al.
Diabetes, Obesity & Metabolism|May 10, 2026
Diabetic Peripheral Neuropathy May Be an Independent Risk Marker for Dementia and Cerebrovascular DiseaseAstrid Wiggers, Vanja Kosjerina, Malin Nilsson, et al.
Journal of Patient Safety|March 6, 2015
Medication Review and Patient Outcomes in an Orthopedic Department: A Randomized Controlled StudyMarianne Lisby, Dorthe Krogsgaard Bonnerup, Birgitte Brock, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 30, 2012
Glucagon-like peptide-1 decreases intracerebral glucose content by activating hexokinase and changing glucose clearance during hyperglycemiaMichael Gejl, Lærke Egefjord, Susanne Lerche, et al.
Diabetes, Obesity & Metabolism|July 8, 2026
Severity of Cardiovascular Autonomic Neuropathy Is Linked to Increasing Levels of Circulating Proinflammatory CytokinesMichelle Damgaard, Marietta Kokla, Rebekka H Gerwig, et al.
Pageof 12